ORGANIZATIONS REPRESENTED AT THE HEARINGS-Continued Narcotic addict rehabilitation agency program, Tulane University: Clark, June, drug addiction research team. Cohen, Dr. Gary, head. Goldsmith, Bernard, systems analyst, drug abuse team. Heath, Dr. Robert G., head, department of social psychiatry. Narcotic Service Council (NASCO)-St. Louis: Harvey, William M., Ph. D., director of psychological services. National Council of Community Mental Health Centers: Levin, Gilbert, Ph. D. Morris, Jonas V., executive director. National Loss Control Service Corp. (NATLSCO), Lewis F. Presnall, manager, corporate alcoholism and other behavioral problems department; and director of rehabilitation, Kemper Insurance Group. New Orleans, La.: Landrieu, Hon. Moon, mayor. Thompson, Dr. Doris, director, city health department. New York City: Finney, Graham S., commissioner, addiction services agency. Lacey, Miss Diane, mayor's office. Lindsay, Hon. John V., mayor. New York State Narcotic Addiction Control Commission: Chambers, Dr. Carl. Hesse, Ray. Jones, Howard, chairman. Parents Foundation Against Drug Abuse: Rembish, Mrs. Helen. Tarantino, Mrs. Mary. Pharmaceutical Manufacturers Association: Adams, Dr. John G., vice president for scientific and professional relations. Cavallito, Dr. Chester J., executive vice president, Ayerst Laboratories. Stetler, C. Joseph, president. Richmond Regional Planning District Commission, M. Miles Matthews, director, council on drug abuse control (CODAC). Rubicon, Inc., Richmond, Va., Edmund Menken, project director. Smith Kline & French Laboratories, Thomas M. Rauch, chairman of the board and president. State Department, Nelson Gross, Senior Adviser to the Secretary of State and Coordinator for International Narcotics Matters. Treasury Department, Eugene T. Rossides, Assistant Secretary (Enforcement, Tariff and Trade Affairs, and Operations. Veterans' Administration: Bronaugh, A. T., Associate General Counsel. Johnson, Donald E., Administrator of Veterans' Affairs. Kaim, Dr. Samuel, Director, Alcohol and Drug Dependence Service. Lee, Dr. Lyndon, Assistant Chief Medical Director for Professional Services. Musser, Dr. Marc J., Chief Medical Director. Peckarsky, J. C., Deputy Chief Benefits Director. Virginia Commonwealth University, Richmond, Va.: Brandt, Dr. Warren W., president. Bright, Dr. George M., director, Adolescent Medicine Medical College of Virginia. Harrison, Willard I., M. Sc., director, department of pharmacy services, and project director, methadone treatment program, Medical College of Virginia. Mathis, Dr. James, professor of psychiatry, Medical College of Virginia. Virginia Council on Narcotics and Drug Abuse Control, F. John Kelly, executive director. 66-841 0-72-pt. 1- -2 SPECIAL ACTION OFFICE FOR DRUG ABUSE PREVENTION MONDAY, JUNE 28, 1971 HOUSE OF REPRESENTATIVES, SUBCOMMITTEE ON PUBLIC HEALTH AND ENVIRONMENT, COMMITTEE ON INTERSTATE AND FOREIGN COMMERCE, Washington, D.C. The subcommittee met at 10 a.m., pursuant to notice, in room 2123 Rayburn House Office Building, Hon. Paul G. Rogers (chairman) presiding. Mrs. ROGERS. The subcommittee will come to order, please. The hearings today are on H.R. 9264, introduced by Chairman Staggers for himself and Mr. Springer at the request of the administration to establish a Special Action Office for Drug Abuse Prevention; H.R. 9059 which I have introduced for myself and the majority of the members of the Health Subcommittee, providing for treatment facilities for drug abusers at community mental health centers; and numerous other bills providing for the establishment of a special office in the Executive Office of the President to deal with problems of drug abuse. There are some 35 bills, I might add. In recent years, drug abuse has become virtually an epidemic in the United States, with serious consequences to the health of the American people. Last year this subcommittee spent 11 days in hearings and 40 days in executive sessions considering overall legislation to deal with the problem. As a result of our study, the Congress enacted a complete revision of all drug laws, to provide more adequate tools for law enforcement authorities to deal with the problem of drug abuse. One of the more difficult areas dealt with in that legislation involved the relative degree of emphasis to be given in handling this problem to balancing the law enforcement approach as contrasted with the medical and rehabilitative approach. The legislation as finally enacted provides, in my opinion, a balanced approach to the problem, but further revisions in Federal laws will aid in carrying out that approach. The bills before us today are designed primarily to bring about more effective Federal programs in the area of education, prevention, and rehabilitation. The President's proposal would establish a single office with responsibility for carrying out all Federal programs outside of the law enforcement area relating to drug abuse. The legislation does not appear to include drug abuse programs administered by the Armed Forces, or responsibilities exercised by the Secretary of State; however, with these exceptions, the legislation appears to cover all Federal programs outside of the law enforcement area. The legislation I have introduced on behalf of the subcommittee would expand treatment programs in the more than 350 community mental health centers we currently have in the United States. Unfortunately, the present programs as to treatment, enforcement, and education are presently administered in a manner that appear to be so weak that compared to need they are almost impotent. I strongly feel that whatever legislation we produce will have as its backbone a network of treatment centers which now exist and will exist in the community mental health facilities in the Nation as well as public health hospitals and clinics. The committee intends to give the various legislative proposals before us the utmost priority. Many programs are already authorized by the Congress. These hearings will be geared to emphasize the use of those present authorities in law and to expand the authority of law where needed. Action is what the American people want, and action is what this committee wants. At this point, there will be included in the record the text of the bills and agency reports thereon. (The text of the bills and departmental reports thereon follow :) [H.R. 9264, 92d Cong., 1st sess., introduced by Mr. Staggers (for himself and Mr. Springer) on June 18, 1971; H.R. 9288, 92d Cong., 1st sess., introduced by Mr. Robinson of Virginia on June 21, 1971; H.R. 9290, 92d Cong., 1st sess., introduced by Mr. Wright on June 21, 1971; H.R. 9690, 92d Cong., 1st sess., introduced by Mr. Patten on July 8, 1971; and H.R. 10810, 92d Cong., 1st sess., introduced by Mr. Broyhill of Virginia on September 22, 1971, are identical as follows:] A BILL To establish a Special Action Office for Drug Abuse Prevention : 1 to concentrate the resources of the Nation in a crusade against Be it enacted by the Senate and House of Representa 2 tives of the United States of America in Congress assembled, 3 That this Act may be cited as the "Special Action Office for 6 7 8 SEC. 2. The Congress hereby finds (1) that drug abuse is rapidly increasing in the United States and now afflicts urban, suburban, and |